The DOI matches its Crossref record; 471 of the 471 references it cites were found in a registry or an index.
Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?
Open accessAbstract
Alzheimer’s disease (AD) is the most prevalent form of dementia. Despite decades of research following several theoretical and clinical lines, all existing treatments for the disorder are purely symptomatic. AD research has traditionally been focused on neuronal and glial dysfunction. Although there is a wealth of evidence pointing to a significant vascular component in the disease, this angle has been relatively poorly explored. In this review, we consider the various aspects of vascular dysfunction in AD, which has a significant impact on brain metabolism and homeostasis and the clearance of β-amyloid and other toxic metabolites. This may potentially precede the onset of the hallmark pathophysiological and cognitive symptoms of the disease. Pathological changes in vessel haemodynamics, angiogenesis, vascular cell function, vascular coverage, blood-brain barrier permeability and immune cell migration may be related to amyloid toxicity, oxidative stress and apolipoprotein E (APOE) genotype. These vascular deficits may in turn contribute to parenchymal amyloid deposition, neurotoxicity, glial activation and metabolic dysfunction in multiple cell types. A vicious feedback cycle ensues, with progressively worsening neuronal and vascular pathology through the course of the disease. Thus, a better appreciation for the importance of vascular dysfunction in AD may open new avenues for research and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–471 of 471
Fazal, K., Perera, G., Khondoker, M. R., Howard, R. J., & Stewart, R. J. (2017) · BJPsych Open · doi:10.1192/bjpo.bp.116.004184 · Cited by 54
Monocytes and Alzheimer’s disease
Feng, Y., Li, L., & Sun, X. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1205-3 · Cited by 53
Servi, B. D., Porta, C. A. M. L., Bontempelli, M., & Comolli, R. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00018-9 · Cited by 53
Wang, Z., Zhang, X., Li, T., Li, J., Tang, Y., & Le, W. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12186 · Cited by 53
Immunotherapy for Alzheimer's Disease: Rational Basis in Ongoing Clinical Trials
Menéndez‐González, M., Pérez‐Piñera, P., Martínez-Rivera, M., Muñíz, A. L., & Vega, J. A. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211795164112 · Cited by 52
Tripathy, D., Thirumangalakudi, L., & Grammas, P. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-11405 · Cited by 51
Increase of white matter string vessels in Alzheimer's disease
CHALLA, V. R., Thore, C. R., Moody, D. M., Anstrom, J. A., & Brown, W. R. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6404 · Cited by 51
de Oliveira, F. F., Chen, E., Smith, M. D. A. C., & Bertolucci, P. H. F. (2017) · Current Alzheimer Research · doi:10.2174/1567205014666171016101816 · Cited by 51
Kalaria, R. N., & Kroon, S. N. (1992) · Acta Neuropathologica · doi:10.1007/bf00227737 · Cited by 50
Paterson, R. W., Bartlett, J. W., Blennow, K., Fox, N. C., Initiative, A. D. N., Shaw, L. M. J., Trojanowski, J. Q., Zetterberg, H., & Schott, J. M. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.58 · Cited by 50
Moon, J. H., Kang, S. B., Park, J. S., Lee, B., Kang, E. S., Ahn, C. W., Lee, H. C., & Soo, B. (2010) · Metabolism · doi:10.1016/j.metabol.2010.08.013 · Cited by 49
Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease
Williams, S., Chalmers, K., Wilcock, G. K., & Love, S. (2005) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2005.00663.x · Cited by 49
Miners, J. S., Kehoe, P. G., & Love, S. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00486.x · Cited by 48
APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice
Kunzler, J., Youmans, K. L., Yu, C., LaDu, M., & Tai, L. M. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.12.032 · Cited by 48
Limbic system perfusion in Alzheimer's disease measured by MRI-coregistered HMPAO SPET
Callen, D. J. A., Black, S. E., & Caldwell, C. B. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-0816-3 · Cited by 47
Mok, S. S., Turner, B. J., Beyreuther, K. T., Masters, C. L., Barrow, C. J., & Small, D. H. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02976.x · Cited by 46
Thrombin induces an inflammatory phenotype in a human brain endothelial cell line
Alabanza, L. M., & Bynoe, M. S. (2012) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2012.02.004 · Cited by 45
Role of the JNK pathway in thrombin-induced ICAM-1 expression in endothelial cells
Miho, N., ISHIDA, T., KUWABA, N., Ishida, M., SHIMOTEABE, K., Tabuchi, K., OSHIMA, T., YOSHIZUMI, M., & Chayama, K. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.05.029 · Cited by 45
Changes in the glucose transporter of brain capillaries
Harik, S. I. (1992) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y92-252 · Cited by 44
Yang, S., Kwon, B., Gho, Y. S., & Chae, C. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02993.x · Cited by 43
Gonzalez‐Velasquez, F. J., & Moss, M. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04988.x · Cited by 43
Thaker, U., McDonagh, A. M., Iwatsubo, T., Lendon, C. L., Pickering-Brown, S. M., & Mann, D. M. A. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00425.x · Cited by 43
Meta-analysis of expression and function of neprilysin in Alzheimer’s disease
Zhang, H., Liu, D., Wang, Y., Huang, H., Zhao, Y., & Zhou, H. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.07.060 · Cited by 42
Vascular pathology in Alzheimer's disease
Miyakawa, T. (2010) · Psychogeriatrics · doi:10.1111/j.1479-8301.2009.00294.x · Cited by 41
Inferior Temporal Lobe Atrophy and APOE Genotypes in Alzheimer’s Disease
Tanaka, S., Kawamata, J., Shimohama, S., Akaki, H., Akiguchi, I., Kimura, J., & Ueda, K. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017029 · Cited by 41
Solerte, S. B., Ferrari, E., Cuzzoni, G., Locatelli, E., Giustina, A., Zamboni, M. M., Schifino, N., Rondanelli, M., Gazzaruso, C., & Fioravanti, M. (2004) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000080963 · Cited by 41
Xu, F., Fu, Z., Dass, S., Kotarba, A. E., Davis, J., Smith, S. O., & Nostrand, W. E. V. (2016) · Nature Communications · doi:10.1038/ncomms13527 · Cited by 41
Ruzali, W. A. W., Kehoe, P. G., & Love, S. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121336 · Cited by 40
Gietl, A. F., Warnock, G., Riese, F., Kälin, A. M., Saake, A., Gruber, E., Leh, S. E., Unschuld, P. G., Kuhn, F. P., Burger, C., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.12.036 · Cited by 40
Kwakowsky, A., Milne, M., Waldvogel, H. J., & Faull, R. L. M. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17122122 · Cited by 40
Self-citationSolito, R., Corti, F., Fossati, S., Mezhericher, E., Donnini, S., Ghiso, J. A., Giachetti, A., Rostagno, A. A., & Ziche, M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.11.002 · Cited by 38
Immunostaining of human brain capillaries by antibodies to very late antigens
McGeer, P. L., Zhu, S. G., & Dedhar, S. (1990) · Journal of Neuroimmunology · doi:10.1016/0165-5728(90)90003-6 · Cited by 38
Hirono, N., Mori, E., Yasuda, M., Ishii, K., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Sasaki, M. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199812000-00018 · Cited by 37
Immunotherapy in Alzheimer’s Disease: Do We Have All the Pieces of the Puzzle?
Sarazin, M., Dorothée, G., de Souza, L. C., & Aucouturier, P. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.04.011 · Cited by 37
Ultrastructural Changes of Blood Vessels in the Cerebral Cortex in Alzheimer's Disease
Higuchi, Y., Miyakawa, T., Shimoji, A., & Katsuragi, S. (1987) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1987.tb00414.x · Cited by 37
Provias, J., & Jeynes, B. (2014) · Current Neurovascular Research · doi:10.2174/1567202611666140520122316 · Cited by 36
Beta‐amyloid 1‐42 monomers, but not oligomers, produce PHF ‐like conformation of Tau protein
Manassero, G., Guglielmotto, M., Zamfir, R. I., Borghi, R., Colombo, L., Salmona, M., Perry, G. L., Odetti, P. R., Arancio, O., Tamagno, E., et al. (2016) · Aging Cell · doi:10.1111/acel.12500 · Cited by 36
Statins and Brain Health: Alzheimer’s Disease and Cerebrovascular Disease Biomarkers in Older Adults
Ramanan, V. K., Przybelski, S. A., Graff‐Radford, J., Castillo, A. M., Lowe, V. J., Mielke, M. M., Roberts, R. O., Reid, R. I., Knopman, D. S., Jack, C. R., et al. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180446 · Cited by 36
Ciallella, J. R., Figueiredo, H. F., Smith‐Swintosky, V. L., & McGillis, J. P. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614537 · Cited by 35
Cessation of Neoangiogenesis in Alzheimer's Disease Follows Amyloid-beta Immunization
Biron, K. E., Dickstein, D. L., Gopaul, R., Fenninger, F., & Jefferies, W. A. (2013) · Scientific Reports · doi:10.1038/srep01354 · Cited by 35
Delacourte, A., Défossez, A., Persuy, P., & Peers, M.-C. (1987) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00735024 · Cited by 35
FGF-2 overexpression opposes the beta amyloid toxic injuries to the vascular endothelium
Donnini, S., Cantara, S., Morbidelli, L., Giachetti, A., & Ziche, M. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401803 · Cited by 35
Estato, V., do Nascimento, A. R., Antunes, B., Gomes, F., Coelho, L. L., Silvares, R. R., Garzoni, L. R., Daliry, A., Bousquet, P., & Tibiriçá, E. V. (2016) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2016.0085 · Cited by 35
ALZHEIMER'S DISEASE AND THE PARIETAL LOBE
Chase, T. N., Foster, N. L., & Mansi, L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90211-8 · Cited by 33
Correction: Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.32 · Cited by 32
Vogelsang, P., Giil, L. M., Lund, A., Vedeler, C. A., Parkar, A. P., Nordrehaug, J. E., & Kristoffersen, E. K. (2017) · Brain Research · doi:10.1016/j.brainres.2017.10.035 · Cited by 32
Høgh, P., Knudsen, G. M., Husted-Kjaer, K., Jørgensen, O. S., Paulson, O. B., & Waldemar, G. (2001) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870101400110 · Cited by 31
Higuchi, M., Arai, H., Nakagawa, T., Higuchi, S., Muramatsu, T., Matsushita, S., Kosaka, Y., Itoh, M., & Sasaki, H. (1997) · Neuroreport · doi:10.1097/00001756-199708180-00001 · Cited by 31
Milne, M., Haug, C. A., Ábrahám, I. M., & Kwakowsky, A. (2014) · Endocrinology · doi:10.1210/en.2014-1669 · Cited by 30
Self-citationvan Dyck, C. H., Gelernter, J. E., MacAvoy, M. G., Avery, R. A., Criden, M., Okereke, O. I., Varma, P., Seibyl, J. P., & Hoffer, P. B. (1998) · Archives of Neurology · doi:10.1001/archneur.55.11.1460 · Cited by 30
Zhuravin, I. A., Nalivaeva, N. N., Kozlova, D. I., Kochkina, E. G., Fedorova, Y. B., & Si, G. (2015) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2015115112110-117 · Cited by 30
Shimizu, S., Kanetaka, H., Hirose, D., Sakurai, H., & Hanyu, H. (2015) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000375527 · Cited by 29
Kehoe, P. G., Davies, N. M., Martin, R. M., & Ben‐Shlomo, Y. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121090 · Cited by 29
Sandoval, K. E., Farr, S. A., Banks, W. A., Crider, A. M., Morley, J. E., & WITT, K. A. (2013) · Brain Research · doi:10.1016/j.brainres.2013.05.006 · Cited by 29
Apolipoprotein E polymorphism influences the cerebral metabolic pattern in Alzheimer's disease
Mielke, R., Zerres, K., Uhlhaas, S., Kessler, J., & Heiß, W.-D. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00673-9 · Cited by 29
Clinical deficits of Alzheimer's disease with cerebrovascular disease and probable VaD.
Erkinjuntti, T. (2001) · PubMed · Cited by 29
Induction of angiogenesis in the ??-amyloid peptide-injected rat hippocampus
Zand, L., Ryu, J. K., & McLarnon, J. G. (2005) · Neuroreport · doi:10.1097/00001756-200502080-00011 · Cited by 28
Effect of Central Cholinergic Stimulation on Regional Cerebral Blood Flow in Alzheimer's Disease
Wilson, K., Bowen, D. M., Francis, P. T., & Tyrrell, P. J. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.158.4.558 · Cited by 27
CEREBRAL ARTERIAL DEFORMITIES IN RELATION TO SENILE DETERIORATION
Beskow, J., HASSLER, O., & Ottosson, J. (1971) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1971.tb02143.x · Cited by 25
Shamieh, S. E., Costanian, C., Kassir, R., Visvikis‐Siest, S., & Bissar‐Tadmouri, N. (2018) · Personalized Medicine · doi:10.2217/pme-2018-0067 · Cited by 25
Apolipoprotein E Genotype and Early Alzheimer's Disease: A Longitudinal SPECT Study
Sakamoto, S., Matsuda, H., Asada, T., Ohnishi, T., Nakano, S., Kanetaka, H., & Takasaki, M. (2003) · Journal of Neuroimaging · doi:10.1111/j.1552-6569.2003.tb00167.x · Cited by 24
Peers, M.-C., Lenders, M.-B., D�fossez, A., Delacourte, A., & Mazzuca, M. (1988) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00749733 · Cited by 23
APOE ε4 and bapineuzumab: Infusing pharmacogenomics into Alzheimer disease therapeutics
Kaufer, D., & Gandy, S. (2009) · Neurology · doi:10.1212/wnl.0b013e3181c6784a · Cited by 21
Amyloid Beta Influences Vascular Smooth Muscle Contractility and Mechanoadaptation
Hald, E. S., Timm, C. D., & Alford, P. W. (2016) · Journal of Biomechanical Engineering · doi:10.1115/1.4034560 · Cited by 21
CSF Biomarkers Correlate with Cerebral Blood Flow on SPECT in Healthy Elderly
Stomrud, E., Forsberg, A., Hägerström, D., Ryding, E., Blennow, K., Zetterberg, H., Minthon, L., Hansson, O., & Londos, E. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000338185 · Cited by 19
Lasser, R. A., Ostrowitzki, S., Scheltens, P., Boada, M., Dubois, B., Dorflinger, E. E., Balas, B., Nikolcheva, T., Volz, D., Ashford, E., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.08.153 · Cited by 19
MR Relative Cerebral Blood Flow Mapping of Alzheimer Disease
Yoshiura, T., Mihara, F., Kuwabara, Y., Ogomori, K., Kaneko, K., Tanaka, A., Sasaki, M., Nakagawa, M., Koga, H., Yamanaka, T., et al. (2002) · Academic Radiology · doi:10.1016/s1076-6332(03)80665-7 · Cited by 14
Impact on Cognitive Function—Are All Statins the Same?
Shah, N. P., Swiger, K. J., & Martin, S. S. (2014) · Current Atherosclerosis Reports · doi:10.1007/s11883-014-0466-5 · Cited by 11
Nishida, Y., Winkler, E. A., Sagare, A. P., Vivo, D. C. D., & Zloković, B. V. (2017) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2017.08.2167 · Cited by 6
Nizari, S., Romero, I. A., & Hawkes, C. A. (2017) · Clinical Science · doi:10.1042/cs20160769 · Cited by 4
(1997) · PubMed
Cited by
The interplay between diet and the gut microbiome: implications for health and disease
Ross, F. C., Patangia, D., Grimaud, G., Lavelle, A., Dempsey, E. M., Ross, R. P., & Stanton, C. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01068-4 · Cited by 638
Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298
Neurovascular Unit Dysfunction and Neurodegenerative Disorders
Yu, X., Ji, C., & Shao, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00334 · Cited by 244
Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00339 · Cited by 170
Cummings, J. L., Atri, A., Feldman, H. H., Hansson, O., Sano, M., Knop, F. K., Johannsen, P., León, T., & Scheltens, P. (2025) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01666-7 · Cited by 168
Metadata
- Authors
- Govindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L., & Kwakowsky, A.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2019-05-10
- Volume
- 8
- Issue
- 5
- Pages
- 651
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W2946791655
- Cited by
- 275
- References
- 471
- FWCI
- 13.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.